Understanding how DDX6 influences FUS protein behavior in neurodegenerative diseases
Defining the Role of DDX6 in Regulating FUS Condensates
This study is looking at how a protein called DDX6 affects another protein, FUS, which is important in conditions like ALS and frontotemporal dementia, to help find new ways to treat these diseases.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10906904 on NIH RePORTER |
What this research studies
This research investigates the role of DDX6, an RNA helicase, in regulating the behavior of FUS, a protein linked to neurodegenerative diseases like amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The study focuses on how DDX6 affects the formation and stability of FUS protein aggregates, which can become harmful when misregulated. By using advanced techniques, including CRISPR, the researchers aim to uncover the mechanisms by which DDX6 influences FUS granule formation and size, potentially leading to new therapeutic strategies for these conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with amyotrophic lateral sclerosis or frontotemporal dementia.
Not a fit: Patients with other neurodegenerative diseases not related to FUS or DDX6 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights and treatments for patients suffering from ALS and frontotemporal dementia.
How similar studies have performed: Previous research has shown promising results in understanding protein aggregation in neurodegenerative diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Mekonnen, Gemechu — Johns Hopkins University
- Study coordinator: Mekonnen, Gemechu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.